Literature DB >> 23960840

Adenosine and its receptors as therapeutic targets: An overview.

Sakshi Sachdeva1, Monika Gupta.   

Abstract

The main goal of the authors is to present an overview of adenosine and its receptors, which are G-protein coupled receptors. The four known adenosine receptor subtypes are discussed along with the therapeutic potential indicating that these receptors can serve as targets for various dreadful diseases.

Keywords:  A1, A2A, A2B, A3 receptors; Adenosine; Purine ribonucleosides

Year:  2012        PMID： 23960840      PMCID： PMC3744929          DOI： 10.1016/j.jsps.2012.05.011

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN： 1319-0164            Impact factor:   4.330


  52 in total

1.  Nondopaminergic symptomatic therapies for Parkinson's disease: turn on or turn off?

Authors:  Andrew Feigin
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

Review 2.  Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands.

Authors:  Stephanie Federico; Giampiero Spalluto
Journal:  Expert Opin Ther Pat       Date:  2012-03-22       Impact factor: 6.674

Review 3.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

4.  4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.

Authors:  Mark A Matulenko; Ernest S Paight; Robin R Frey; Arthur Gomtsyan; Stanley DiDomenico; Meiqun Jiang; Chih-Hung Lee; Andrew O Stewart; Haixia Yu; Kathy L Kohlhaas; Karen M Alexander; Steve McGaraughty; Joseph Mikusa; Kennan C Marsh; Steven W Muchmore; Clarissa L Jakob; Elizabeth A Kowaluk; Michael F Jarvis; Shripad S Bhagwat
Journal:  Bioorg Med Chem       Date:  2006-12-20       Impact factor: 3.641

Review 5.  Shaping of monocyte and macrophage function by adenosine receptors.

Authors:  György Haskó; Pál Pacher; Edwin A Deitch; E Sylvester Vizi
Journal:  Pharmacol Ther       Date:  2006-09-14       Impact factor: 12.310

6.  Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.

Authors:  Kenneth A Ellenbogen; Gearoid O'Neill; Eric N Prystowsky; John A Camm; Lixin Meng; Hsiao Dee Lieu; Markus Jerling; Revati Shreeniwas; Luiz Belardinelli; Andrew A Wolff
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

7.  Localization of the adenosine A1 receptor subtype gene (ADORA1) to chromosome 1q32.1.

Authors:  A Townsend-Nicholson; E Baker; P R Schofield; G R Sutherland
Journal:  Genomics       Date:  1995-03-20       Impact factor: 5.736

Review 8.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1994-08       Impact factor: 14.819

Review 9.  Pharmacology and therapeutic applications of A1 adenosine receptor ligands.

Authors:  Arvinder K Dhalla; John C Shryock; Revati Shreeniwas; Luiz Belardinelli
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

Review 10.  Adenosine, inflammation and asthma--a review.

Authors:  M Livingston; L G Heaney; M Ennis
Journal:  Inflamm Res       Date:  2004-04-21       Impact factor: 4.575
View more
  38 in total

1.  Antinociceptive and neurochemical effects of a single dose of IB-MECA in chronic pain rat models.

Authors:  Stefania Giotti Cioato; Liciane Fernandes Medeiros; Bettega Costa Lopes; Andressa de Souza; Helouise Richardt Medeiros; José Antônio Fagundes Assumpção; Wolnei Caumo; Rafael Roesler; Iraci L S Torres
Journal:  Purinergic Signal       Date:  2020-11-08       Impact factor: 3.765

2.  Disruption of hepatic one-carbon metabolism impairs mitochondrial function and enhances macrophage activity in methionine-choline-deficient mice.

Authors:  Brandon J Eudy; Caitlin E McDermott; Gabriel Fernandez; Clayton E Mathews; Jinping Lai; Robin P da Silva
Journal:  J Nutr Biochem       Date:  2020-03-19       Impact factor: 6.048

Review 3.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

4.  Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.

Authors:  Nikkita Puri; Vinita Mohey; Manjinder Singh; Tajpreet Kaur; Devendra Pathak; Harpal Singh Buttar; Amrit Pal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-04       Impact factor: 3.000

5.  Novel Adenosine Analog, N6-(4-Hydroxybenzyl)-Adenosine, Dampens Alcohol Drinking and Seeking Behaviors.

Authors:  Sa-Ik Hong; Lee Peyton; Yijuang Chern; Doo-Sup Choi
Journal:  J Pharmacol Exp Ther       Date:  2019-08-13       Impact factor: 4.030

Review 6.  The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.

Authors:  Elham Safarzadeh; Farhad Jadidi-Niaragh; Morteza Motallebnezhad; Mehdi Yousefi
Journal:  Inflamm Res       Date:  2016-03-09       Impact factor: 4.575

Review 7.  Erythrocyte purinergic signaling components underlie hypoxia adaptation.

Authors:  Kaiqi Sun; Hong Liu; Anren Song; Jeanne M Manalo; Angelo D'Alessandro; Kirk C Hansen; Rodney E Kellems; Holger K Eltzschig; Michael R Blackburn; Robert C Roach; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2017-06-01

8.  Dynamic Changes of Astrocytes and Adenosine Signaling in Rat Hippocampus in Post-status Epilepticus Model of Epileptogenesis.

Authors:  Siqi Hong; Tingsong Li; Yuanyuan Luo; Wenjuan Li; Xiaoju Tang; Yuanzhen Ye; Peng Wu; Qiao Hu; Li Cheng; Hengsheng Chen; Li Jiang
Journal:  Cell Mol Neurobiol       Date:  2018-05-16       Impact factor: 5.046

Review 9.  CD39-adenosinergic axis in renal pathophysiology and therapeutics.

Authors:  Bellamkonda K Kishore; Simon C Robson; Karen M Dwyer
Journal:  Purinergic Signal       Date:  2018-01-13       Impact factor: 3.765

Review 10.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.